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ABSTRACT 
Three new contact lens solutions have recently been approved 
by the FDA for one-step disinfection of soft contact lenses: Alcon's 
Opti-OneTM, Allergan's COMPLETE®, and Ciba's Quick CARE™. These 
solutions are indicated for use in the disinfection, daily cleaning, 
rinsing and storing of soft contact lenses. They are approved for 
direct placement on the eye with soft contact lenses. This 
investigation compared the relationship between the three solutions 
and subjective ocular comfort/sensitivity. Ninety subjects 
participated in one of three experimental sessions to compare the 
ophthalmic solutions. Ratings for ocular surface sensitivity to Opti-
OneTM, Quick CARE™, and COMPLETE®, demonstrated no statistically 
significant change from pre-instillation to post-instillation conditions. 
In addition, there was no consistent pattern of preference for one 
solution over another. In fact, in direct comparison of solutions, over 
forty percent of subjects reported no difference in ocular comfort. 
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Background: 
Three new contact lens solutions have recently been approved 
by the FDA for one-step disinfection of soft contact lenses: Alcon's 
Opti-One™, Allergan's COMPLETE®, and Ciba's Quick CARE™. These 
solutions are indicated for use in the disinfection, daily cleaning, 
rinsing and storing of soft contact lenses. They are approved for 
direct placement on the eye with soft con~act lenses. Ideally, these 
solutions should exert minimal toxicity and not in sensitivity 
reactions. Ocular sensitivity to ophthalmic solutions can be caused 
by several factors; type of preservative, pH, and osmolarity. These 
factors vary for different ophthalmic solutions. Therefore, it IS 
important to address each of these separately. 
Traditional disinfecting solutions containing chlorhexidine, 
thimerosal, or other mercury-containing ingredients have been 
shown to be toxic to the cornea. 1 •2 COMPLETE® by Allergan utilizes 
polyhexamethylene biguanide (PHMB) as a disinfectant/preservative . 
PHMB is the same molecule as polyaminopropyl biguanide (PAPB) 
found in ReNu® Multi-Purpose Solution, but the two molecules differ 
in chemical structure of their monomer units. COMPLETE® (with 1 
ppm PHMB) has higher D values (time to kill 1 log unit or 90% of test 
bacteria) in comparison to ReNu® (0.5 ppm PAPB).3,4 Opti-One's 
Polyquad® is the same disinfectant/preservative used in its Opti-
free™ formulation. Antimicrobial efficacy (D values) of Opti-One ™ is 
comparable to COMPLETE®. Direct comparative studies have shown 
that the Quick CARE™ system, containing isopropyl alcohol, exhibits 
the greatest antimicrobial efficacy of the four soft contact lens 
solutions. 4 
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The difference in pH between ophthalmic solutions and the tear 
layer can lead to corneal sensitivity reactions. The tears act to buffer 
instilled solutions. Studies have shown that the pH of the tear layer 
will return to normal ranges in 2-5 minutes after instillation of 
ophthalmic solutions with pH-5 and pH-9.5 The pH of the tears 
ranges from 7.14 to 7.82 with a mean pH of 7.45.6 However, the tear 
pH of dry eye patients has been found to be higher than that of 
normal patients.? Motolko and Breslin found that patients with dry 
eyes prefer tear substitutes with high pH. 8 There appears to be less 
likelihood of ocular irritation if the pH of an instilled ophthalmic 
solution is comparable to that of the patients own tear pH. Buffers 
added to contact lens solutions stabilize the pH, and maintain the 
solution's pH for hydrolysis of proteins. Citrate (Opti-OneT~), 
tromethamine (COMPLETE®), and borate (Quick CARETM) are common 
to contact lens solutions. Tromethamine has been shown to have a 
higher buffering capacity than citrate or borate.3 Thus, the buffering 
capability of ophthalmic solutions decreases ocular irritation by 
maintaining pH and minimizing shifts associated with the instillation 
of ophthalmic solutions. 
The hypertonicity of the ophthalmic contact lens solutions, 
relative to normal tear osmolarity, can also contribute to ocular 
sensitivity reactions. Tear osmolarity is a factor of the concentration 
of electrolytes in the tears. Gilbard found that the osmolarity of 
tears is elevated in patients with keratoconjunctivitis sicca? 
Decreased blink rate and aqueous evaporation increase the tonicity 
of the tear layer. In addition, contact lens wearers exhibit increased 
tear osmolarity, and long term contact lens wear has been shown to 
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decrease corneal sensitivity_lO Studies by Gilbard have further 
shown that decreasing corneal sensitivir 
by approximately 70%. 11 This decrea: 
subsequent increase in tear layer osmol 
corneal epithelium changes. 9 Thus, cl 
layer, through the instillation of hypen 
disrupts the corneal epithelial layer ar 
Ocular surface sensitivity vanes 
structures in the eye. Millodot found 
greatest in the anterior portion of the 
the limbus. 12 This directly correlate: 
highest density in the center and dec 
periphery. 13 In comparison, conJunc· 
levels of sensitivity. At the lid marf 
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of corneal touch sensitivity, after extended periods of contact lens 
wear, can take a period of days to weeks. 19' 20 This implies that 
long-term contact lens wearers may display decreased corneal 
sensitivity to ophthalmic solutions in comparison to non-contact lens 
wearers. 
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METHODS 
Ninety subjects, between the ages of 20 and 56 years, were 
recruited from the student and faculty population at Pacific 
University in Forest Grove, OR. The following subjects were excluded 
from participation in the study: subjects under the age of 18, 
pregnant females and nursing mothers, those with current ocular 
infections or corneal disruptions, and those with ocular or systemic 
contraindications or allergies to any of the ophthalmic solutions used 
in the study. Subjects included 43 males and 47 females. Forty-
seven (52.2%) of the subjects wore soft contact lenses, sixteen 
(17.8%) wore RGP's, and twenty-seven (30%) did not wear contact 
lenses. Subjects were not excluded from the study as a factor of 
contact lens wear. 
Subjects participated m one of three experimental sessions to 
compare subjective ocular sensitivity of the following SCL solutions: 
Allergan COMPLETE®, Alcon Opti-One™, and Ciba Quick CAREn.t. SCL 
solutions were paired into three groups according to session: Group I 
(Alcon/Ciba), Group II (Alcon/Allergan), and Group III 
(Ciba/ Allergan). This was done in order to allow for direct subjective 
comparison of one solution to another. A total of 180 eyes were 
tested in the study (60 for each solution). 
Prior to beginning the study, SCL solutions were transferred to 
identical sterile dropper bottles and labeled A, B, and C (A=Opti-
One™, B=Quick CARE™, and C=COMPLETE®). Subjects were given a 
questionnaire to assess ocular comfort prior to instillation of the 
drops (appendix A). Subjects rated different symptoms on a scale of 
one to seven (none-severe) for each eye separately. One solution 
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was randomly chosen to be instilled in one eye, while the 
contralateral eye received the other paired solution. One drop 
(approx. 40 ul) of each solution was instilled to simulate the amount 
of solution that would be received upon SCL insertion. Solutions 
were instilled onto the inferior conjunctiva with the patient looking 
up. Subjects were instructed to look straight ahead and blink 
normally. Drops were instilled by the same researcher for all 
conditions utilizing identical instillation techniques. The study was 
double masked so the subject and the researcher were not aware of 
which solutions were being instilled. 
Two minutes after instillation of the drops, subjects filled out a 
post instillation questionnaire assessing subjec6ve ocular comfort. 
The questionnaire was identical to the initial questionnaire, except 
for the inclusion of questions regarding patient contact lens wear 
(appendix B). 
The same protocols were followed for each of the three 
experimental sessions. 
RESULTS: 
Each of the ten rated symptoms were summed and averaged 
over all subjects. Due to the nature of the grading scale, and as 
measures were intra-subject, an analysis of variance (ANOV A) test 
was used to analyze the data. Ratings for ocular surface sensitivity 
to Opti-One™, Quick CARETM, and COiviPLETE®, demonstrated no 
statistically significant change from 'pre-instillation to post-
instillation (tables 1-1 0). The average changes in lid sensitivity from 
pre to post-instillation conditions are shown in figure 1. Lid itchiness 
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and redness decreased for all three solutions, while lid burning 
increased with Opti-OneTM and Quick CARE™, but decreased with 
COMPLETE®. Subjects also rated Quick CARE™ and COMPLETE® as 
causing an increase in lid puffiness. 
Figure 2 shows the average subjective change in ocular surface 
sensitivity, for the six rated items. Ocular surface itchiness, burning, 
and tearing all increased in symptomology, while redness, dryness, 
and sensitivity to lights decreased in symptomology. 
The change m sensitivity from pre-instillation to post-
instillation conditions for Opti-One™, relative to all ten rated 
measures, are shown in figure 3. Lid burning and ocular surface 
itching, burning and tearing, all increased after instillation of the 
Opti-One™. In comparison, lid itching, puffiness, and redness 
decreased, as did ocular redness, dryness, and light sensitivity. Of all 
the items assessed, ocular surface dryness showed the largest change 
from the pre-instillation to post-instillation conditions. Figures 4 and 
5 show similar results for Quick CARE"N and COMPLETE®. There was 
very little change in lid sensitivity measures from the pre-instillation 
to post-instillation questionnaires for Quick CARE™ (figure 4 ). Ocular 
surface itching, burning, and tearing increased, while redness, 
dryness and light sensitivity decreased. Ocular surface dryness agam 
exhibited the largest change; three times larger than any of the other 
measure. In comparison, COMPLETE® showed modest increases in lid 
puffiness, and ocular surface itching, burning and tearing from the 
pre-instillation to post-instillation conditions (figure 5). On the other 
hand, lid burning, and redness, and ocular surface redness, dryness, 
and sensitivity to lights all decreased in symptomology . 
lO 
Intra-subject direct companson of ocular comfort for the three 
different paired solutions revealed that forty percent of subjects m 
groups I and III, and forty-three percent of group II subjects 
reported no difference in ocular comfort when comparing one drop to 
another. Of those subjects in Group I (Opti-Onent/Quick CARETM) that 
reported a difference in ocular comfort, 61% rated Quick CARETM as 
less irritating to the ocular surfaces than Opti-One™ (39% ). Group II 
(QuickCARETMf COMPLETE®) subjects reporting a difference in ocular 
comfort preferred COMPLETE® (75%) over Quick CARE™ (25%), and 
Group III (Opti-OneTMJCOMPLETE®) showed no preference for 
COMPLETE® (50%) over Opti-OneTM (50%). Contact lens wearers did 
not show a statistically significant difference in ocular sensitivity or 
irritation, post instillation, in comparison to non-contact lens wearers. 
Assessment of disinfecting solutions used by soft contact lens 
wearers in the investigation revealed a variety of solution brands. 
Overall, 38 .8% used Renu®, 34.7% Opti-Free™, 8.1% Quick CARE™, and 
6.1% COMPLETE®. These four accounted for 87.7% of all brands. 
Discussion: 
The results of this investigation indicate that there is no 
statistically significant difference m sensitivity/irritation between 
the three soft contact lens solutions. Quick CARE™, Opti-OneTM, and 
COMPLETE® all showed relatively little change in ocular irritation 
from pre-instillation to post-instillation subjective assessments. Each 
of the solutions, although differing in chemical composition for 
disinfecting and buffering agents, appear to be comparable m 
subjective comfort. 
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In addition, direct comparison of one contact lens solution to 
another failed to reveal a clear subjective preference. In comparing 
Opti-One™ to Quick CARE™, subjects preferred Quick CARE™, while 
subjects comparing Quick CARE™ to COMPLETE® preferred 
COMPLETE®. Comparison of Opti-One™ to COMPLETE® showed equal 
numbers of subjects preferred COMPLETE® as those that preferred 
Opti-One™. There was no consistent pattern of preference for one 
solution over another. In fact, in direct comparison of solutions, forty 
percent of subjects in groups I and III, and forty-three percent of 
subjects in group II reported no difference in ocular comfort. 
Studies have shown that eyes exposed to RGP solutions exhibit 
corneal epithelial toxicity and staining.21 ,22 Begley found significant 
corneal staining with the use of Boston Advance Conditioning 
Solution. 21 This accounts for the high percentage of patients 
reacting to the solution. Boston Advance Conditioning Solution™ 
contains polyaminopropyl biguanide (PAPB) the same 
disinfectant/preservative present in ReNu®, and similar to 
polyhexamethylene biguanide (PHMB) in COMPLETE®. Decreased 
corneal irritation with COMPLETE® and ReNu®, in comparison to 
Boston, can be accounted for by their relative low concentration of 
PAPB and PHMB. Boston Advance Conditioning Solution™ contains 30 
to 50 times higher concentrations.22 Thus, the results of this 
investigation can in part be attributed to the relatively low 
concentrations of disinfecting agents in the solutions. 
An unexpected result of the investigation was the decrease in 
subjective symptoms of ocular dryness from pre-instillation to post-
instillation for all three contact lens solutions. This result may be 
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due to an increase in reflex tearing m response to the ophthalmic 
solutions, or to the wetting effect of the solutions on the cornea. 
Subjective ratings showed that tearing increased for all three 
solutions post-instillation. In comparing the change in tearing from 
pre to post-instillation, we found that the increase in tearing was far 
less than the rated decrease in ocular dryness. Therefore, the change 
in ocular dryness cannot be accounted for simply as a factor of reflex 
tearing, but must also be a factor of the wetting effect of the 
solutions. 
Only one subject reported an adverse reaction any of the soft 
contact lens solutions. The subject complained of a itchy, red eye 
within 15 minutes of instillation of Quick CARETM. Investigators 
evaluated the ocular surfaces and found palpebral and conjunctival 
hyperemia ( +2), and mild chemosis. The patient was dispensed 
artificial tears and returned 2 hours later. Objective evaluation of 
ocular surfaces revealed no hyperemia or chemosis; no subjective 
complaints were reported at this time. Patient history revealed no 
prior history of reactions to any soft contact lens solutions. 
Our results indicate that all three soft contact lens solutions are 
comparable in ocular comfort. Practitioners should consider patient 
history of solution reactions, compliance, and motivation in deciding 
which solution will work best for their patients. 
13 
REFERENCES 
1. Gasset AR. Benzalkonium chloride toxicity ot the human 
cornea. Am J Ophthalmol 1977; 84: 169-171. 
2. Green K, Livingston V, Bowman K, Hull DS. Chlorhexidine 
effects on corneal epithelium and endothelium. Arch 
Ophthalmol 1980; 98: 1273-1278. 
3. Complete Technical Report Series. Allergan, Inc. 1994; 
I :2. 
4. Barr JT. What you need to know about solution 
interactions. CL Spectrum 1994; 8:19. 
5. Nom M. Tear pH after instillation of buffer in vivo. Acta 
Ophalmol Suppl 1985; 173:32. 
6. Carney LG, Hill RM. Human tear pH. Arch Ophthalmol 
1979; 94:821. 
7. Andres S, Garcia ML, Espina M et al. Tear pH, air 
pollution, and contact lenses. Am J Optom Physiol Opt 
1988; 65:627. 
8. Motolko M, Breslin CW. The effect of pH and osmolarity 
on the ability to tolerate artificial tears. Am J Ophthalmol 
1981; 91:781. 
9. Gilbard JP, Rossi SR, Gray KL, Hanninen LA, Kenyon KR. 
Tear film osmolarity and ocular surface disease in two 
rabbit models for keratoconjunctivitis sicca. Invest 
Ophthalmol Vis Sci 1988; 29:374. 
10. Gilbard JP, Gray KL, Rossi SR. A proposed mechanism for 
increased tear film osmolarity in contact lens wearers. 
Am J Ophthalmol 1986; 102:505. 
11. Gilbard JP, Dartt DA. Changes in rabbit lacrimal gland 
fluid osmolarity with flow rate. Invest Ophthalmol Vis 
Sci 1982; 23:804. 
12. Millodot M, Larson W. New measurements of corneal 
sensitivity: A preliminary report. Am J optom Am Acad 
Optom 1969; 46:261. 
13. Sturghold H. The mechanical threshold of the cornea -
reflex of usual laboratory animals. Am J Physiol 1930; 
94:235-6. 
14. Lowther GE, Hill RM. Sensitivity threshold of the lower 
lid margin in the course of adaptation to contact lenses. 
Am J Optom 1968; 45:587. 
1 5. Millodot M. Effect of soft lenses on corneal sensitivity. 
Acta Ophthalmol 197 4; 52:603. 
14 
1 6. Millodot M. Effect of hard contact lenses on croneal 
sensitiVIty. Acta Ophthalmol 1975; 53:576. 
17. Madigan MC, Holden BA, Kwok LS. Extendedn wear of 
contact lenses can compromise epithelial adhesion. 
Current Eye Research 1987; 6:1257. 
1 8. Hamano H, Hori M, Hirayama K. The effect of hard and 
soft contact lenses on rabbit corneas. Contacto 1972; 
16:26. 
19. Millodot M. Does long term wear of contact lenses 
produce a loss of corneal sensitivity? Experientia 1977; 
33:1475. 
20. Tanelian DL, Beuerman RW. Recovery of corneal 
sensation following hard contact lens wear and the 
implication for adaptation. Invest Ophthalmol Vis Sci 
1980; 19: 1391. 
21. Begley CG, Weirich B, Benak J, Pence NA. Effects of rigid 
gas permeable contact lens solutions on the human 
corneal epithelium. Optom Vis Sci 1992; 69,5:347-353. 
22. Begley CG, Waggoner PJ, Hafner GS, Tokarski T, Meetz RE. 
Effect of rigid gas permeable contact lens wetting 
solutions on the rabbit corneal epithelium. Optom Vis Sci; 
68,3:189-197. 
15 
Figure 1 
AL·ilch Bl.·ilch CL·itcn 
AL·rad Sl.-rad Cl-red 
Figure 2 
AE-bum BE-bum ce.oom 
AE-taar BE·toat CE-taar 
AE-photo 3E-;;hoto CC--or.oto 
Figure 3 
0.3 
0.2 
0.1 
Cl) 
C) 0 r::: 
(IS 
.I: 
CJ 
-0.1 
-11'1 
0 
-0.2 ' a. ' 
-
Cl) 
.... 
-0.3 ' a. .... 
J_ 
-0.4 
-0.5 I 
-0.6 
..c c 
(.) ..... 
::l 
.0 
"0 ..c c ..... "0 >- 0 
::l Ql 
.2 ..... (1j Ql ..... ...... 0... ..... ::l Ql ..... "0 0 
.0 ..c 
0... 
Opti-One 
Figure 4 
0.2 
0.1 
0 
Q) 
Ol 
-0 . 1 c 
ra 
..c. 
(,) 
-0 .2 
-1/) 
0 
-0.3 
c.. 
-Q) 
-0.4 .... c.. 
-0.5 
-0.6 
-0.7 
..c. c: 
u ...... ::::: 
.0 
-
"'0 ..c. c: ...... "'0 >- 0 
- Q) ...... ro Q) 
.._ 
..... ::::: u 
0.. 
.._ ::::: Q) .... "'0 0 
.0 ..c. 
a. 
Quick CARE 
Figure 5 
0.2 
0.1 
¢) 0 Cl 
c: 
ctl 
..c: 
-0.1 (.,) 
-tJ) 
0 
-0.2 c. 
-
¢) 
... 
c. 
-0.3 
-0.4 
-0.5 
.!: c 
(.) .... 
-
:::! 
..0 
0.. 
Complete 
Appendix A 
CONTACT LENS SOLUTION SENSITIVITY STUDY 
DA1E: 
PATIENT INITIALS: 
GROUP: 
RANDOMIZED: 
SUBJECTIVE QUESTIONNAIRE: 
I. LIDS: Rate the following symptoms, with regard to how your eyelids 
feel today, on the following scale: 
1------2------3------4------ 5------6------ 7 
none mild moderate severe 
Right Lid Left Lid 
Itching: 
Burning: 
Puffiness: 
Redness: 
II. EYES: Rate the following symptoms, with regard to how your eyes fee 1 
today , on the following scale: 
l------2------3------4------5------6------7 
ftching: 
Burning: 
Tearing : 
Redness : 
Dryness : 
Sensitivity to 
lights: 
none mild moderate severe 
Ri~ht Eye Left Eye 
III. In comparing overall comfort, which is the most true: 
right eye is more comfortable than left: 
left eye is more comfortable than right: 
both eyes are the same: 
Appendix B 
PATIENT INITIALS: 
SUBJECTIVE QUESTIONNAIRE: 
(Please again rate how your eyes feel after receiving eyedrops) 
I . LIDS: Rate the symptoms on the following scale, with regard to how 
your eyelids feel now after the drops were instilled: 
1------2------3------4------5------6------7 
none mild moderate severe 
Right Lid Left Lid 
Itching: 
Burning: 
Puffiness: 
Redness: 
II . EYES: Rate the symptoms on the following scale. with regard to how 
your eyes feel now after the drops were instilled: 
l- ---- -2------3------4 -- ----5-- ----6------7 
Itching: 
Burning: 
Tearing: 
Redness: 
Dryness: 
Sensitivity to 
lights: 
none mild moderate severe 
Ri&:ht Eve Left Eye 
III. In comparing overall comfort. which is the most true : 
IV. 
right eye is more comfortable than left: 
left eye is more comfortable than right: 
both eyes are the same: 
Background: 
Do you currently wear contact lenses : 
Type of lenses worn : 
How long have worn lenses (yrs) : 
Name of cleaning solution used: 
y 
Soft 
N 
Hard 
Table 1 
One Factor ANOVA-Repeated Measures for X1 .•. X3 
Source: df: Sum of Squares: Mean Square: F-test: P value· 
Between subjects 59 39.133 .663 2.595 .0001 
Within subjects 120 30.667 .256 
treatments 2 .233 .117 .452 .6372 
residual 118 30.433 .258 
Total 179 69.8 
Reliability Estimates for- All treatments: .615 Single Treatment: .34 7 
One Factor ANOVA-Repeated Measures for X1 .•. X3 
Group: c aunt: M ean: S d D t . ev.: S d E t . rror: 
AL-itch 60 -.083 .462 .06 
BL-itch 60 -.017 .567 .073 
CL-itch 60 0 .803 .104 
One Factor ANOVA-Repeated Measures for X1 ... X3 
Comparison: Mean Di ff .. F' h PLSD 1s er S h ff F c e e -test: D unnett t: 
AL-itch vs. BL-itch -.067 .1 54 .258 .719 
AL-itch vs. CL-itch -.083 .1 54 .404 .899 
BL-itch vs. CL-itch -.017 .1 54 .016 .18 
Table 2 
One Factor ANOVA-Repeated Measures for X1 ... X3 
Source: df: Sum of Squares: Mean Square: F-test· P value· 
Between subjects 59 33.978 .576 2.16 .0002 
Within subjects 120 32 .267 
treatments 2 .078 .039 .144 .8663 
residual 118 31.922 .271 
Total 179 65.978 
Reliability Estimates for- All treatments: .537 Single Treatment: .279 
One Factor ANOVA-Repeated Measures for X1 ..• X3 
G roup: c t oun: M ean: Std D ev.: Std E rror: 
AL-burn 60 .033 .52 .067 
BL-burn 60 .017 .596 .077 
CL-bum 60 
' 
-.017 .701 .09 
One Factor ANOVA-Repeated Measures for X1 ... X3 
c amp anson: M ean I .. Fi h PLSD 1s er ShffFtt c e e - es : D unne tt t 
AL-burn vs. BL-burn .017 . 157 .015 .176 
AL-burn vs. CL-bum .OS .1 57 .139 .527 
BL-burn vs. CL-burn .033 .1 57 .062 .351 
Table 3 
One Factor ANOVA-Repeated Measures for X1 ••. X3 
Source: df: Sum of Squares· Mean Square· F-test· P value· 
Between subjects 59 49.811 .844 2.554 .0001 
Within subjects 120 39.667 .331 
treatments 2 1.303 .651 2.004 .1394 
residual 118 38.364 .325 
Total 179 89.478 
Reliability Estimates for- All treatments: .608 Single Treatment: .341 
One Factor ANOVA-Repeated Measures for X1 ... X3 
G roup: c aunt: M ean: s d 0 t . ev.: S d E t . rror: 
AL-puff 60 -.108 .402 .052 
BL-puff 60 .083 .809 .104 
CL-puff 60 .058 .824 .1 06 
One Factor ANOVA-Repeated Measures for X1 ... X3 
c ompanson: M ean I .. F' h PLSO 1s er S h ff F c e e -test: 0 unnett t: 
AL-puff vs. BL-puff -.192 .173* 1.695 1.841 
AL-puff vs. CL-puff -.167 .173 1.282 1.601 
BL-puff vs. CL-puff .025 .173 .029 .24 
* Significant at 90% 
Table 4 
One Factor ANOVA-Repeated Measures for X1 .•• X3 
Source: df: Sum of Squares: Mean Square: F-test· P value· 
Between subjects 59 54.578 .925 2.523 .0001 
Within subjects 120 44 .367 
treatments 2 .211 .1 06 .284 .7529 
residual 118 43.789 .371 
Total 179 98.578 
Reliability Estimates for- All treatments: .604 Single Treatment: .337 
One Factor ANOVA-Repeated Measures for X1 ... X3 
Group: c aunt: Mean: S d D t . ev.: d St . Error: 
AL-red 60 -.133 .596 .077 
BL-red 60 -.05 .723 .093 
CL-red 60 -.083 .889 .11 5 
One Factor ANOVA-Repeated Measures for X1 ... X3 
c ompanson: ean D'ff 1 .. R h PLSD ts er S h ff F t c e e - est: D unnett t: 
AL-red vs. BL-red -.083 .184 .281 .749 
AL-red vs. CL-red -.05 .184 .1 01 .45 
BL-red vs. CL-red .033 .184 .045 .3 
Table 5 
One Factor ANOVA-Repeated Measures for X1 ••• X3 
Source: df: Sum of Squares: Mean Square: F-test: P value· 
Between subjects 59 54.91 1 .931 2.018 .0006 
Within subjects 120 55.333 .461 
treatments 2 .411 .206 .442 .644 
residual 118 54.922 .465 
Total 179 110.244 
Reliability Estimates for- All treatments: .505 Single Treatment: .253 
One Factor ANOVA-Repeated Measures for X1 ••• X3 
G roup: c aunt: M ean: s d 0 t . ev.: S d E t . rror: 
AE-ich 60 .083 .72 .093 
BE-itch 60 .2 .798 .1 03 
CE-itch 60 . 1 5 .84 .1 08 
One Factor ANOVA-Repeated Measures for X1 ••. X3 
c amp anson: M ean t .. Fi h PLSO 1s er S h ff F c e e -test: 0 unnett t: 
AE-ich vs. BE-itch -.117 .207 .439 .937 
AE-ich vs. CE-itch -.067 .207 .143 .535 
BE-itch vs. CE-itch .OS .207 .081 .401 
Table 6 
One Factor ANOVA-Repeated Measures for X 1 ... X3 
Source: df: Sum of Squares: Mean Square: F-test· P value· 
Between subjects 59 72.728 1.233 1.585 .0173 
Within subjects 120 93.333 .778 
treatments 2 1.378 .689 .884 .4158 
residual 118 91.956 .779 
Total 179 166.061 
Reliability Estimates for- All treatments: .369 Single Treatment: .163 
One Factor ANOVA-Repeated Measures for X1 ... X3 
G roup: c aunt: M ean: S d D t . ev.: S d E t . rror: 
AE-burn I so .25 1.144 .148 
BE-bum 60 .083 .787 .1 02 
CE-burn 60 .OS .928 .12 
One Factor ANOVA-Repeated Measures for X1 ... X3 
c ompanson: M ean I .. Fi h PLSD 1s er S h ff F t c e e - est: 0 unne tt t 
AE-burn vs. BE-bum .167 .267 .535 1.034 
AE-burn vs. CE-burn .2 .267 .77 1.241 
BE-bum vs. CE-bum .033 .267 .021 .207 
Table 7 
One Factor ANOVA-Repeated Measures for X 1 ... X3 
Source: df: Sum of Squares: Mean Square: F-test· P value· 
Between subjects 59 25.394 .43 2.279 .0001 
Within subjects 120 22.667 .189 
treatments 2 1.011 .506 2.755 
.0677 
residual 118 21.656 .184 
Total 179 48.061 
Reliability Estimates for- All treatments: .561 Single Treatment: .299 
One Factor ANOVA-Repeated Measures for X1 ... X3 
G roup: c ount: M ean: S d D t . ev.: d St . Error: 
AE-tear 60 .233 .647 .084 
BE-tear 60 .083 .497 .064 
CE-tear 60 .067 .362 .047 
One Factor ANOVA-Repeated Measures for X1 ... X3 
c amp anson: M ean Off i .. Fi h p IS er LSD: h ff F Sc e e -test: 0 unnett t: 
AE-tear vs. BE-tear .1 5 .13* 1.839 1.91 8 
AE-tear vs. CE-tear .167 .13* 2.27 2.131 
BE-tear vs. CE-tear .017 .13 .023 .213 
* Significant at 90% 
Table 8 
One Factor AN OVA-Repeated Measures for X 1 ... X3 
Source: df: Sum of Squares: Mean Square· F-test· P value· 
Between subjects 59 46.867 .794 2.103 .0003 
Within subjects 120 45.333 .378 
treatments 2 .7 .35 .925 .3993 
residual 118 44.633 .378 
Total 179 92.2 
Reliability Estimates for- All treatments: .524 Single Treatment: .269 
One Factor ANOVA-Repeated Measures for X1 .•. X3 
G roup: c t oun: M ean: Std D ev.: Std E rror: 
AE-red 60 -.117 .783 .1 01 
BE-red 60 -.017 .701 .09 
CE-red 60 -.167 .668 .086 
One Factor ANOVA-Repeated Measures for X1 ... X3 
Camp anson: M ean D'ff I .. Fi h PLSD 1s er S h ff F c e e -test: D unnett t: 
AE-red vs. BE-red -.1 .186 .397 .891 
AE-red vs. CE-red .OS .186 .099 .445 
BE-red vs. CE-red .15 .186 .892 1.336 
Table 9 
One Factor ANOVA-Repeated Measures for X1 ... X3 
Source: df: Sum of Squares: Mean Square: F-test: P value· 
Between subjects 59 1 1 3.24 1.92 2.93 .0001 
Within subjects 120 78.67 .66 
treatments 2 1.01 .51 .77 .4661 
residual 118 77.66 .66 
Total 179 191.91 
Reliability Estimates for- All treatments: .66 Single Treatment: .39 
One Factor ANOVA-Repeated Measures for X1 ... X3 
G roUQ: c aunt: Mean: Std. Dev.: Std. Error: 
AE-dry 60 -.58 1 . 13 
BE-dry 60 -.67 1.1 6 . 15 
CE-dry 60 -.48 .95 . 12 
One Factor ANOVA-Repeated Measures for X1 ... X3 
c ompanson: M ean o·ff I .. F' h PLSD 1s er S h ff F c e e -test: Dunnett t: 
AE-dry vs. BE-dry . 08 .29 . 16 .56 
AE-dry vs. CE-dry -.1 .29 .23 .68 
BE-dry vs. CE-dry -.18 .29 .77 1.24 
Table 10 
One Factor ANOVA-Repeated Measures for X 1 ..• X3 
Source: df: Sum of Squares: Mean Square: F-test: P value· 
Between subjects 59 40.311 .683 1.922 .0013 
Within subjects 120 42.667 .356 
treatments 2 .544 .272 .763 .4687 
residual 118 42.122 .357 . 
Total 179 82.978 
Reliability Estimates for- All treatments: .48 Single Treatment: .235 
One Factor ANOVA-Repeated Measures for X1 ... X3 
Group· Count· Mean· Std Dev · .. Std Error· 
AE-photo 60 -.35 .777 . 1 
BE-photo 60 -.217 .454 .059 
CE-photo 60 -.3 .766 .099 
One Factor ANOVA-Repeated Measures for X1 ... X3 
Comparison· Mean Diff · .. Fisher PLSD· Scheffe F-test· Dunnett t· 
AE-photo vs. BE-photo -.133 .181 .747 1.222 
AE-photo vs. CE-photo -.05 .181 .105 .458 
BE-photo vs. CE-photo .083 .181 .292 .764 
